Logo

American Heart Association

  12
  0


Final ID: Mo2102

Physicians’ Misrecognition of Stroke Risk in Patients with Atrial Fibrillation

Abstract Body (Do not enter title and authors here): Background: Current clinical practice guidelines for atrial fibrillation (AF) recommend stroke risk stratification and the use of oral anticoagulants (OACs) for patients at risk. However, physicians’ recognition of patients’ stroke risk may differ from the calculated risk, and the effect of this discrepancy on subsequent care remains unknown.
Aims: We aimed to document treating physicians’ estimations of individual patients' stroke risk and assess its association with OAC utilization.
Methods: A multicenter, prospective cohort study was conducted in two outpatient practices in Tokyo, Japan, between 2018 to 2020. Participants included patients with newly diagnosed AF or those referred for initial treatment for AF. Treating physicians were asked to document the patient's estimated risk of stroke in numbers. The estimations were categorized as low risk (<1.0%/year), intermediate risk (1.0%≤ to <2.0%/ year), and high risk (2.0%≤/year). We then calculated patients’ baseline CHA2DS2-VASc scores and divided them into three risk groups: 0 or 1 point as low risk, 2 points as intermediate risk, and 3 or more points as high risk. Higher risk categorization by physicians was defined as "overestimation," while lower risk categorization was defined as "underestimation." The independent association of physician-patient risk concordance with OAC use was explored by multivariable Logistic regression models.
Results: Among the 285 patients enrolled in this study (mean age 68±12 years, male 72.6%), the mean CHA2DS2-VASc score was 2.3±1.6. Physicians correctly estimated stroke risk in 147 patients (51.6%), underestimated it in 25 patients (8.8%) and overestimated it in 113 patients (39.6%). OACs were used in 89.8% of patients whose stroke risk was correctly estimated, 72.0% of those whose stroke risk was underestimated, and 84.1% of patients whose health status was overestimated. After multivariable adjustment, the underestimation of stroke risk was independently associated with less use of OACs (adjusted odds ratio 0.23, 95% CI 0.061-0.85, P=0.028).
Conclusions: In this cohort study, physician underestimation of stroke risk was not rare and associated with less use of OACs.
  • Miyama, Hiroshi  ( Keio University School of Medicine , Tokyo , Japan )
  • Ikemura, Nobuhiro  ( Saint Lukes Mid America Heart Inst , Shawnee , Kansas , United States )
  • Kimura, Takehiro  ( Keio University School of Medicine , Tokyo , Japan )
  • Katsumata, Yoshinori  ( Keio University School of Medicine , Tokyo , Japan )
  • Ueda, Ikuko  ( Keio University School of Medicine , Tokyo , Japan )
  • Tanimoto, Kojiro  ( NHO Tokyo National Center , Tokyo , Japan )
  • Takatsuki, Seiji  ( Keio University School of Medicine , Tokyo , Japan )
  • Kohsaka, Shun  ( Keio University School of Medicine , Tokyo , Japan )
  • Ieda, Masaki  ( Keio University School of Medicine , Tokyo , Japan )
  • Author Disclosures:
    Hiroshi Miyama: DO NOT have relevant financial relationships | Nobuhiro Ikemura: DO have relevant financial relationships ; Research Funding (PI or named investigator):Bristol Myers Squibb:Past (completed) | Takehiro Kimura: DO NOT have relevant financial relationships | Yoshinori Katsumata: No Answer | Ikuko Ueda: No Answer | Kojiro Tanimoto: No Answer | Seiji Takatsuki: DO have relevant financial relationships ; Speaker:Medtronic:Active (exists now) ; Speaker:Japan Lifeline:Active (exists now) ; Speaker:Boston Scientific:Active (exists now) | Shun Kohsaka: No Answer | Masaki Ieda: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

EP Potpourri #2

Monday, 11/18/2024 , 10:30AM - 11:30AM

Abstract Poster Session

More abstracts on this topic:
A First-in-Class Humanized Antibody Fragment Targeting Platelet Glycoprotein Ibα: A Comprehensive Preclinical Study of CA1001 for the Treatment of Acute Ischemic Stroke

Xu Xiaohong, Preeti Preeti, Yu Ruoying, Shaykhalishahi Hamed, Zhang Cheng, Shen Chuanbin, Li Bei, Tang Naping, Chang Yan, Xiang Qian, Cui Yimin, Lei Xi, Ni Heyu, Zhu Guangheng, Liu Zhenze, Hu Xudong, Slavkovic Sladjana, Neves Miguel, Ma Wenjing, Xie Huifang

A novel risk score predicts the prevalence of left atrial low-voltage areas and rhythm outcome in patients undergoing long-standing persistent atrial fibrillation ablation

Ooka Hirotaka, Nakao Sho, Kusuda Masaya, Ariyasu Wataru, Kudo Satoshi, Fujii Subaru, Mano Toshiaki, Matsuda Yasuhiro, Masuda Masaharu, Okamoto Shin, Ishihara Takayuki, Nanto Kiyonori, Tsujimura Takuya, Hata Yosuke, Uematsu Hiroyuki

More abstracts from these authors:
Influences of Age on Improvement of Health-Related Quality of Life in Patients with Atrial Fibrillation following Initial Treatment

Nakamaru Ryo, Takatsuki Seiji, Spertus John, Ieda Masaki, Ikemura Nobuhiro, Kohsaka Shun, Kimura Takehiro, Yoshinori Katsumata, Nishiyama Takahiko, Ueda Ikuko, Tanimoto Kojiro, Negishi Koji

Changes in Contrast Volume among Patients Undergoing Percutaneous Coronary Intervention: a Report from NCDR CathPCI registry

Ikemura Nobuhiro, Chan Paul, Cohen David, Kennedy Kevin, Uzendu Anezi, Kohsaka Shun, Spertus John

You have to be authorized to contact abstract author. Please, Login
Not Available